what's Sharps Technology?
Sharps Technology is a medical device company listed on NASDAQ under the ticker STSS, which has pivoted to integrate blockchain technology by adopting Solana as its primary digital asset for treasury management. This positions it as a pioneer in institutional-grade digital asset treasuries, bridging traditional finance with Web3 ecosystems. The company leverages Solana's high-throughput blockchain to hold and manage SOL tokens, enabling efficient, low-cost transactions and staking opportunities within its corporate treasury strategy. Through strategic partnerships, such as with Crypto.com and Pudgy Penguins, Sharps Technology expands connectivity in the Solana ecosystem. These collaborations focus on enhancing exposure to digital assets for institutional players, including token bundles and public listings. The initiative aims to set standards for internet capital markets by combining regulatory compliance with blockchain innovation. The @stsssol handle serves as the dedicated X presence for its Solana treasury activities, sharing updates on ecosystem integrations and thought leadership in digital asset adoption.
Sharps Technology expanded Coinbase partnership for institutional Solana validator launch today.
Links
x.com/stsssolExpanded partnership with Coinbase Institutional to launch a jointly supported institutional-grade Solana validator operated by Coinbase on January 12, 2026.
DATs like the project validate LSTs as the foundation for institutional participation in Solana DeFi.
The project's leader is participating as a speaker at B3's inaugural DAT summit covering digital asset treasuries and public listings at Token2049.
An ATM (At-The-Market offering) mechanism is planned, which will increase the project's future buying power and funding capabilities.
The project has accumulated $400M worth of SOL in their treasury, representing significant capital allocation activity.